Title |
Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial
|
---|---|
Published in |
BMC Pregnancy and Childbirth, May 2013
|
DOI | 10.1186/1471-2393-13-102 |
Pubmed ID | |
Authors |
Marianne AC Verschoor, Marike Lemmers, Patrick M Bossuyt, Giuseppe CM Graziosi, Petra J Hajenius, Dave J Hendriks, Marcel AH van Hooff, Hannah S van Meurs, Brent C Opmeer, Maurits W van Tulder, Liesanne Bouwma, Ruby Catshoek, Peggy Geomini, Ellen R Klinkert, Josje Langenveld, Theodoor E Nieboer, J Marinus van der Ploeg, Celine M Radder, Taeke Spinder, Lucy F van der Voet, Ben Willem J Mol, Judith AF Huirne, Willem M Ankum |
Abstract |
Medical treatment with misoprostol is a non-invasive and inexpensive treatment option in first trimester miscarriage. However, about 30% of women treated with misoprostol have incomplete evacuation of the uterus. Despite being relatively asymptomatic in most cases, this finding often leads to additional surgical treatment (curettage). A comparison of effectiveness and cost-effectiveness of surgical management versus expectant management is lacking in women with incomplete miscarriage after misoprostol. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 50% |
Ireland | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 58 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 9 | 16% |
Other | 8 | 14% |
Student > Ph. D. Student | 7 | 12% |
Researcher | 6 | 10% |
Student > Master | 6 | 10% |
Other | 11 | 19% |
Unknown | 11 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 34 | 59% |
Nursing and Health Professions | 4 | 7% |
Social Sciences | 3 | 5% |
Economics, Econometrics and Finance | 2 | 3% |
Immunology and Microbiology | 1 | 2% |
Other | 2 | 3% |
Unknown | 12 | 21% |